These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10970247)

  • 1. Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders.
    Saiz A; Graus F; Dalmau J; Pifarré A; Marin C; Tolosa E
    Ann Neurol; 1999 Nov; 46(5):774-7. PubMed ID: 10970247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of 14-3-3 brain protein in the cerebrospinal fluid of patients with paraneoplastic neurological disorders.
    Saiz A; Graus F; Dalmau J; Pifarre A; Marin C; Tolosa E
    Ann Neurol; 1999 Nov; 46(5):774-7. PubMed ID: 10553996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic usefulness of the determination of protein 14-3-3 in cerebrospinal fluid in Creutzfeld-Jakob disease].
    Sáiz A; Marín C; Tolosa E; Graus F
    Neurologia; 1998; 13(7):324-8. PubMed ID: 9810794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients.
    Kenney K; Brechtel C; Takahashi H; Kurohara K; Anderson P; Gibbs CJ
    Ann Neurol; 2000 Sep; 48(3):395-8. PubMed ID: 10976650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid.
    Collins S; Boyd A; Fletcher A; Gonzales M; McLean CA; Byron K; Masters CL
    J Clin Neurosci; 2000 May; 7(3):203-8. PubMed ID: 10833616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical algorithm for cerebrospinal fluid test of 14-3-3 protein in diagnosis of Creutzfeldt-Jacob disease].
    Lemstra AW; van Meegen M; Baas F; van Gool WA
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1467-71. PubMed ID: 11503317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cerebrospinal fluid diagnosis of Creutzfeldt-Jakob disease].
    Bernheimer H; Gatterbauer B; Radbauer C; Budka H
    Wien Med Wochenschr; 1998; 148(4):96-100. PubMed ID: 9611349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease.
    Geschwind MD; Martindale J; Miller D; DeArmond SJ; Uyehara-Lock J; Gaskin D; Kramer JH; Barbaro NM; Miller BL
    Arch Neurol; 2003 Jun; 60(6):813-6. PubMed ID: 12810484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel binding assay for detection of 14-3-3 protein in cerebrospinal fluid from Creutzfeldt-Jakob patients.
    Leuck J; Peoch K; Laplanche JL; Grabar E; Müller WE; Schröder HC
    Cell Mol Biol (Noisy-le-grand); 2000 Nov; 46(7):1291-6. PubMed ID: 11075958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Creutzfeldt-Jakob disease: diagnostic value of protein 14-3-3 and neuronal specific enolase assay in cerebrospinal fluid].
    Brandel JP; Beaudry P; Delasnerie-Lauprêtre N; Laplanche JL
    Rev Neurol (Paris); 1999 Feb; 155(2):148-51. PubMed ID: 10226319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients.
    Van Everbroeck B; Dobbeleir I; De Waele M; De Deyn P; Martin JJ; Cras P
    J Neurol; 2004 Mar; 251(3):298-304. PubMed ID: 15015009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.
    Hsich G; Kenney K; Gibbs CJ; Lee KH; Harrington MG
    N Engl J Med; 1996 Sep; 335(13):924-30. PubMed ID: 8782499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autopsy-proven Creutzfeldt-Jakob disease in a patient with a negative 14-3-3 assay and nonspecific EEG and MRI.
    Donahue JE; Hanna PA; Hariharan S
    Neurol Sci; 2004 Feb; 24(6):411-3. PubMed ID: 14767688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease.
    Satoh K; Shirabe S; Tsujino A; Eguchi H; Motomura M; Honda H; Tomita I; Satoh A; Tsujihata M; Matsuo H; Nakagawa M; Eguchi K
    Dement Geriatr Cogn Disord; 2007; 24(3):207-12. PubMed ID: 17690553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Eleven years of autopsy on account of Creutzfeldt-Jakob disease in the Netherlands].
    Jansen C; Schuur M; Spliet WG; van Gool WA; van Duijn CM; Rozemuller AJ
    Ned Tijdschr Geneeskd; 2009; 153():A172. PubMed ID: 19785859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted MRI in Creutzfeldt-Jakob disease: a better diagnostic marker than CSF protein 14-3-3?
    Mendez OE; Shang J; Jungreis CA; Kaufer DI
    J Neuroimaging; 2003 Apr; 13(2):147-51. PubMed ID: 12722497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease.
    Brechlin P; Jahn O; Steinacker P; Cepek L; Kratzin H; Lehnert S; Jesse S; Mollenhauer B; Kretzschmar HA; Wiltfang J; Otto M
    Proteomics; 2008 Oct; 8(20):4357-66. PubMed ID: 18814332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CSF-analyses in clinical diagnosis of Creutzfeldt-Jakob disease. A literature review and three cases from routine clinical practice].
    Blennow K; Lind B; Andersson E; Andreasen N
    Lakartidningen; 2001 May; 98(20):2446-51. PubMed ID: 11433975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease.
    Zerr I; Bodemer M; Gefeller O; Otto M; Poser S; Wiltfang J; Windl O; Kretzschmar HA; Weber T
    Ann Neurol; 1998 Jan; 43(1):32-40. PubMed ID: 9450766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14-3-3 protein levels and isoform patterns in the cerebrospinal fluid of Creutzfeldt-Jakob disease patients in the progressive and terminal stages.
    Shiga Y; Wakabayashi H; Miyazawa K; Kido H; Itoyama Y
    J Clin Neurosci; 2006 Jul; 13(6):661-5. PubMed ID: 16815706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.